Study #2022-0052
A prospective study of conventional bone marrow biopsies and bone marrow biopsies performed through an indwelling bone marrow port, using a modified PROMIS pain intensity scale for pain assessment
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This is a self-controlled, prospective trial. The objective of this trial is to evaluate the efficacy and safety of the Portomar(TM) device for bone marrow biopsy.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Hematologic Malignancy
Study phase:
Not applicable
Physician name:
Rahul Sheth
Department:
Lymphoma/Myeloma
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.